eFFECTOR Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	15.51	14.88	8.71	49.7	15.22	3.43
Short-Term Investments	9.88	3.5	17.6	-	-	-
Cash & Short-Term Investments	25.38	18.37	26.31	49.7	15.22	3.43
Cash Growth	33.55%	-30.18%	-47.06%	226.64%	344.00%	-
Other Receivables	0.02	0.05	0.03	-	-	-
Receivables	0.02	0.05	0.03	-	-	-
Prepaid Expenses	0.85	1.42	1.68	3.19	1.36	0.85
Total Current Assets	26.25	19.84	28.01	52.9	16.58	4.27
Property, Plant & Equipment	0.42	0.19	0.35	0.26	0.13	0.82
Other Long-Term Assets	0.47	0.51	0.71	0.9	-	-
Total Assets	27.13	20.54	29.08	54.06	16.7	5.1
Accounts Payable	1.71	2.33	1.49	0.52	0.35	0.6
Accrued Expenses	3.79	2.92	3.37	3.07	1.63	2.65
Short-Term Debt	-	-	-	-	-	14.73
Current Portion of Long-Term Debt	20.02	20.49	20.16	-	5.91	-
Current Portion of Leases	0.05	0.06	0.06	0.04	0.11	0.51
Current Income Taxes Payable	-	-	-	0.35	0.35	-
Other Current Liabilities	-	-	-	-	0.43	0.44
Total Current Liabilities	25.57	25.8	25.08	3.98	8.78	18.93
Long-Term Debt	-	-	-	19.86	6.95	-
Long-Term Leases	0.18	-	0.06	0.13	-	-
Other Long-Term Liabilities	0.56	0.54	0.05	12.81	-	-
Total Liabilities	26.3	26.34	25.18	36.77	15.73	18.93
Common Stock	-	-	-	0	-	-
Additional Paid-In Capital	189.04	173.58	147.48	138.18	4.45	3.85
Retained Earnings	-188.21	-179.38	-143.57	-120.9	-136.7	-150.91
Comprehensive Income & Other	-	-	-0.02	-	-	-
Total Common Equity	0.83	-5.8	3.9	17.28	-132.25	-147.06
Shareholders' Equity	0.83	-5.8	3.9	17.28	0.98	-13.84
Total Liabilities & Equity	27.13	20.54	29.08	54.06	16.7	5.1
Total Debt	20.25	20.55	20.28	20.03	12.96	15.25
Net Cash (Debt)	5.14	-2.18	6.03	29.67	2.26	-11.82
Net Cash Growth	-	-	-79.68%	1215.83%	-	-
Net Cash Per Share	1.84	-0.99	3.66	20.60	21.23	-247.06
Filing Date Shares Outstanding	4.7	3.69	1.7	1.66	1.63	0.05
Total Common Shares Outstanding	3.9	2.98	1.67	1.62	1.45	0.05
Working Capital	0.68	-5.96	2.94	48.92	7.8	-14.66
Book Value Per Share	0.21	-1.94	2.34	10.70	-91.51	-3074.38
Tangible Book Value	0.83	-5.8	3.9	17.28	-132.25	-147.06
Tangible Book Value Per Share	0.21	-1.94	2.34	10.70	-91.51	-3074.38
Machinery	0.34	0.26	0.24	0.22	0.23	2.09
Construction In Progress	0.01	0.01	0.03	0.07	-	-
Leasehold Improvements	0.19	0.19	0.19	-	-	1.07

Updated May 9, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.